TMDX
HEALTHCARETransmedics Group Inc
$72.92-22.01 (-23.19%)PRE
Live · NASDAQ · May 9, Close
AI Insight
What's Moving TMDX Today?
No stock-specific AI insight has been generated for TMDX yet. Check back soon — insights are generated from recent news analysis.
52-Week Range
$70.00$156.00
$72.92
Fundamentals
Market Cap$2.5B
P/E Ratio15.0
EPS$4.87
Dividend Yield—
Dividend / Share—
ROE0.5%
Profit Margin0.3%
Debt / Equity—
Trading
Volume7.8M
Avg Volume (10D)—
Shares Outstanding34.6M
TMDX News
22 articles- TransMedics Group Inc (TMDX) Q1 2026 Earnings Call Highlights: Strong Revenue Growth Amid ...Yahoo Finance·May 8, 2026
- TransMedics Group, Inc. (NASDAQ:TMDX) Given Average Rating of "Moderate Buy" by BrokeragesMarketBeat·May 8, 2026
- Glucotrack Submits Blood Glucose Monitoring Technology to FDAYahoo Finance·May 7, 2026
- My Top 3 Stocks to Buy in MayMotley Fool·May 7, 2026
- TransMedics Group (NASDAQ:TMDX) Given New $124.00 Price Target at Canaccord Genuity GroupMarketBeat·May 7, 2026
- TMDX Dips After Posting Q1 Earnings & Revenue Miss, Margins FallYahoo Finance·May 6, 2026
- TransMedics (TMDX) Q1 2026 Earnings TranscriptMotley Fool·May 6, 2026
- AMD upgraded, Reddit downgraded: Wall Street's top analyst callsYahoo Finance·May 6, 2026
- TransMedics Group, Inc. Q1 2026 Earnings Call SummaryMoby·May 6, 2026
- TransMedics Group Q1 Earnings Call HighlightsMarketbeat·May 6, 2026
- TransMedics (TMDX) Reports Q1 Earnings: What Key Metrics Have to SayYahoo Finance·May 5, 2026
- TransMedics (TMDX) Q1 Earnings and Revenues Miss EstimatesYahoo Finance·May 5, 2026
- TransMedics Reports First Quarter 2026 Financial ResultsYahoo Finance·May 5, 2026
- TransMedics Group Announces Intent to Create the First Dedicated European Transplant Logistics Network with Strategic Investment in PAD Aviation service GmbHYahoo Finance·Apr 29, 2026
- TransMedics Unveils CHOPS As Trials Progress And Valuation Screens UndervaluedYahoo Finance·Apr 27, 2026
- Is TransMedics Group, Inc. (TMDX) A Good Stock To Buy Now?Yahoo Finance·Apr 24, 2026
- TransMedics to Provide Update on Ongoing Clinical Programs at the International Society of Heart and Lung Transplantation 2026 Annual MeetingYahoo Finance·Apr 23, 2026
- TransMedics to Report First Quarter 2026 Financial Results on May 5, 2026Yahoo Finance·Apr 21, 2026
- 2 Healthcare Stocks That Could Outperform the Market Over the Next DecadeMotley Fool·Apr 16, 2026
- Does TransMedics Group's (TMDX) Cash Flow Turn and Fleet Expansion Reshape Its Capital Allocation Story?Yahoo Finance·Apr 14, 2026
- TransMedics Group (TMDX) Is Down 7.1% After Expanding Its National OCS Transplant Platform AmbitionsYahoo Finance·Mar 26, 2026
- TransMedics (TMDX) Down 20.3% Since Last Earnings Report: Can It Rebound?Yahoo Finance·Mar 26, 2026
All 22 articles loaded
Price Data
Open$100.97
Previous Close$94.93
Day High$101.70
Day Low$98.26
52 Week High$156.00
52 Week Low$70.00
52-Week Range
$70.00$156.00
$72.92
Fundamentals
Market Cap$2.5B
P/E Ratio15.0
EPS$4.87
Dividend Yield—
Dividend / Share—
ROE0.5%
Profit Margin0.3%
Debt / Equity—
Trading
Volume7.8M
Avg Volume (10D)—
Shares Outstanding34.6M
About Transmedics Group Inc
TransMedics Group, Inc., a commercial-stage medical technology company, is dedicated to transforming organ transplant therapy for patients with end-stage organ failure in the United States and internationally. The company is headquartered in Andover, Massachusetts.
HEALTHCAREMEDICAL DEVICES
Company Details
Security TypeStock
ExchangeNASDAQ
CurrencyUSD
Round Lot—
SICMEDICAL DEVICES
CIK—
Composite FIGI—
Share Class FIGI—